School of Medicine
Showing 21-40 of 342 Results
-
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Sepideh Bajestan, MD, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsNeuropsychiatry
Functional Neurological Symptom Disorders, Psychogenic Non-Epileptic Seizures
Group and Individual Psychotherapy
Impulse Control Disorders -
Julie Baker
Professor of Genetics
Current Research and Scholarly InterestsWe examine how cells communicate and function during fetal development. The work in my laboratory focuses on the establishment of specific cell fates using genomics to decipher interactions between chromatin and developmental signaling cascades, between genomes and rapidly evolving cell types, and between genomic copy number variation and gene expression. In recent years we have focused on the vastly understudied biology of the trophoblast lineage, particularly how this lineage evolved.
-
Justin Nathaniel Baker
Deborah E. Addicott - John A. Kriewall and Elizabeth A. Haehl Family Professor of Pediatrics
BioAs a Pediatric Oncologist, Palliative Care Physician, and Phase I and End– of– Life Care Clinical Investigator, I am intimately aware of the distress experienced by children with advanced cancer and the ethical and end– of– life/bereavement issues surrounding their disease progression. I currently serve as the Chief of the Division of Quality of Life and Pediatric Palliative Care here at Stanford, as well as the Director of the Quality of Life for All (QoLA) Program. Additionally, I serve as the Associate Chief Quality Officer for Patient Experience and Holistic Care. In my past career at St Jude, I served as the Director of our large Pediatric Hematology/Oncology Fellowship Program for more than a decade. My research interests include ethical considerations surrounding enrollment in Phase I clinical trials, AYA palliative oncology care, end– of– life decision making, grief and bereavement, integrating palliative care into the ongoing care of children with cancer as well as patient– reported outcomes and pain and symptom control in the context of pediatric oncology care. I have received significant extramural funding for my research, and I have participated in dozens of studies related to pediatric palliative care. I have authored ~250 academic works on palliative care subjects within the context of pediatric oncology. In sum, I am a recognized global expert and leader in the field of Pediatric Palliative Care.
-
Laurence Baker
Bing Professor of Human Biology, Senior Fellow at the Stanford Institute for Economic Policy Research and Professor, by courtesy, of Economics
Current Research and Scholarly InterestsDr. Baker's research is in the area of health economics, and focuses on the effects of financial incentives, organizational structures, and government policies on the health care delivery system, health care costs, and health outcomes.
-
Matthew C. Baker, MD MS
Assistant Professor of Medicine (Immunology and Rheumatology)
BioDr. Baker is the Clinical Chief in the Division of Immunology and Rheumatology at Stanford University and the Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker has established a clinical research program that is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials with a focus on sarcoidosis, IgG4-related disease, Sjogren's syndrome, and rheumatoid arthritis. He also utilizes large databases to study osteoarthritis, with an interest in repurposing existing drugs for the treatment of osteoarthritis.
-
Karthik Balakrishnan, MD, MPH, FAAP, FACS
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsDr. Balakrishnan's research focuses on innovative ways to improve and standardize treatments and measure outcomes in complex pediatric airway and aerodigestive conditions , as well as ways to reduce treatment costs and medical errors. By improving outcomes and reducing costs, he aims to improve the value of care, while also optimizing patient and caregiver experience during the care process.
-
Malathi Balasundaram
Clinical Associate Professor, Pediatrics - Neonatal and Developmental Medicine
Current Research and Scholarly InterestsFamily-centered Care in the NICU
-
Imelda Balboni
Clinical Associate Professor, Pediatrics - Rheumatology
Current Research and Scholarly InterestsPediatric systemic lupus erythematosus;
Autoimmune disease;
Proteomics and autoantigen microarray technology -
Jacob S. Ballon
Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJacob S. Ballon, M.D., M.P.H. specializes in the treatment of people with psychotic disorders including schizophrenia. He is the Co-Director of the INSPIRE Clinic at Stanford which provides interdisciplinary care for people experiencing psychosis. He is also the co-Division Chief for General Adult Psychiatry and Psychology in the Department of Psychiatry. Dr. Ballon completed his residency at Stanford in 2009 and a Schizophrenia Research Fellowship at Columbia University in 2011.
Dr. Ballon maintains an interest in understanding the connections between the brain and the rest of the body as relates to the manifestation and treatment of people who experience psychosis. He works closely with a diverse group of researchers throughout the university and technology community to investigate these connections. He has active projects investigating the metabolic implications of schizophrenia and of psychiatric medication including the association of antipsychotic medication with weight gain and insulin resistance. He also is an active investigator in clinical trials of new medications for the treatment of schizophrenia and the associated side effects of antipsychotic mediations.
In understanding the whole-body impact of psychiatric illness, Dr. Ballon also has an active interest in the role that exercise can play in psychiatric treatment. He is the site-principal investigator of an NIMH-funded clinical trial looking at the use of aerobic exercise to improve cognition in people with schizophrenia.
INSPIRE is an innovative interdisciplinary client-centered resource providing respectful evidence-based care to support people to achieve meaningful recovery from psychosis through collaborative partnership with individuals and their families while advancing knowledge and training for a new generation of providers. With a recovery-oriented philosophy, the clinic provides an array of services including psychopharmacology, psychotherapy, and psychosocial evaluations. As a research clinic, they are focused on collaborating with multiple disciplines throughout the university to conduct clinical and basic science research including functional imaging, clinical trials, basic pathophysiology, and genetics. -
Stephanie Balters
Instructor, Psychiatry and Behavioral Sciences - Interdisciplinary Brain Sciences
BioDr. Stephanie Balters is an instructor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is the director of the Empowerment Neuroscience Laboratory and studies how social factors such as interpersonal trauma and cultural biases impact brain function and mental health outcomes. Dr. Balters develops evidence-based interventions to improve well-being, work productivity, and team performance. She is passionate about embracing authenticity, vulnerability, and individual differences, and leveraging adverse experiences towards self-growth and achieving one’s full potential. Dr. Balters holds a Bachelor's and Master's degree in Mechanical Engineering and has earned a Ph.D. in Engineering Design. Her diverse career journey includes experiences at the Center for Design Research and Computer Science at Stanford University before transitioning to the School of Medicine. Dr. Balters is a Human Factors Specialist at NATO and facilitates Empowerment Workshops at Stanford University.